Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 70, 2015 - Issue 1
46
Views
6
CrossRef citations to date
0
Altmetric
Original Papers

Patient and graft outcome in current era of immunosuppression: a single centre pilot study

, , , , , , , , , , , , , & show all

References

  • Knight SR, Russell NK, Barcena L, Morris PJ. Mycophenolate mofetyl decreases acute rejection and may improve graft survival in renal transplant recipients when compared with azathioprine: a systematic review. Transplantation. 2009;87:785–94.
  • Goldman M, Van Laethem JL, Abramowicz D, De Pauw L, Kinnaert P, Vereerstraeten P. Evolution of renal function during treatment of kidney graft rejection with OKT3 monoclonal antibody. Transplantation. 1990;50:158–9.
  • KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. Chapter 1: Induction therapy. AJT 2009;9(Suppl 3):S6–9.
  • Paul LC. Chronic allograft nephropathy: an update. Kidney Int. 1999;56:783–93.
  • Vereerstraeten P, Wissing M, Broeders N, Hoang AD, Mikhalski D, Donckier V, et al. Vingt-cinq ans d’utilisation des inhibiteurs de la calcineurine en transplantation rénale à l’Hôpital Erasme. Rev Med Brux. 2010;31:41–9.
  • Wujciak T, Opelz G. A proposal for improved cadaver kidney allocation. Transplantation. 1993;5:1513–7.
  • Vereerstraeten P. Préparation du receveur de greffe rénale. In: Hervé P, editor. Transplantation d’organes et greffe de tissus. : INSERM; 1994. p. 690–700.
  • Liptak P, Ivanyi B. Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts. Nat Clin Pract Nephrol. 2006;2:398–404.
  • De Meester J, Persijn DD, Wujciak T, Opelz G, Vanrenterghem Y. The new Eurotransplant kidney allocation system: report one year after implementation. Transplantation. 1998;66:1154–9.
  • Abacus concepts. Survival tools for StatView. : Abacus Concepts; 1994.
  • Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology. 2007;73:435–46.
  • Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, Limaye AP, et al. Polyomavirus-associated nephropathy in renal transplantation: interdiciplinary analyses and recommendations. Transplantation. 2005;79:1277–86.
  • Issa N, Cosio FG, Gloor JM, Sethi S, Dean PG, Moore SB, et al. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation. 2008;86(5):681–5.
  • Susal C, Döhler B, Opelz G. Presensitized kidney graft recipients with HLA Class I and II antibodies are at increased risk for graft failure. A collaborative Transplant Study Report. Human Immunol. 2009;70(8);569–73.
  • Perez Valdivia MA, Gentil MA, Toro M, Cabello M, Rodriguez-Benot A, Mazuecos A. Impact of cold ischemia time on initial graft function and survival rates in renal transplants from deceased donors performed in Andalusia. Transplant Proc. 2011;43(6):2174–6.
  • Doxiadis IIN, de Fijter JW, Mallat MJK, Haasnoot GW, Ringers J, Persijn GG, et al. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation. 2007;83:1207–13.
  • Doxiadis IIN. Compatibility and kidney transplantation: the way to go. Front Immunol. 2012;3:111–3.
  • Opelz G, Wujciak T, Döhler B, Scherer S, mytilineos J. HLA compatibility and organ Transplant survival. Rev Immunogen. 1999;1:334–42.
  • Leivestad T, Reisaeater AV, Brekke IB, Vartdal F, Thorsby E. The role of HLA matching in renal transplantation : experience from one center. Rev Immunogen. 1999;1:343–50.
  • Cicciarelli J, Terasaki PI, Mickey MR. The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant recipients. Transplantation. 1987;43:636–40.
  • Eurotransplant International Foundation. In: Rahmel A, editor. Annual report 2013. Leiden: Foundation EI. p. 48–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.